About Global Antiviral Journal

Aims and Scope
Global Antiviral Journal publishes peer-reviewed original works related to international efforts to advance antiviral discovery and development, including full-length articles and short papers, as well as solicited review articles, conference reports, letters and book reviews. Occasional supplements contain conference abstracts, presentations and/or posters from international meetings in the field of virology and antiviral research. The scope of the journal encompasses chemistry and biological advances in the fundamental as well as clinical study of antiviral diseases and their treatment. Areas covered include HIV, hepatitis B, hepatitis C and emerging viruses, co-infections, vaccines, animal models, pharmacology, microbicides, alternative therapies, viral dynamics and resistance issues.

The journal is published quarterly online by IHL Press.
All printed supplements are also available online.

Publication Policy
Global Antiviral Journal publishes only original, documented research of high scientific quality, following accepted ethical standards of research. Submission of a manuscript signifies that it has been neither copyrighted, published, nor submitted or accepted for publication elsewhere. 

Editor-in-Chief
Raymond F. Schinazi, Frances Winship Walters Professor
Emory University/VA Medical Center
Laboratory of Biochemical Pharmacology
1760 Haygood Dr NE
Ste. E420
Atlanta, GA 30322 USA

Editorial Office
IHL Press, Division of Informed Horizons, LLC
7484 Roller Road Burkburnett, TX 76354
Telephone: +
Fax: +

Subscription Details
Subscription prices are available upon request from the Publisher. All inquiries should be directed to the Editorial Office.

Advertising and Supplements
All advertising enquiries and supplement proposals, including advertising within supplements, should be directed to the Editorial Office.